Clover Wolf Capital - Limited Partnership insider trades: Pluristem Therapeutics (PSTI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Clover Wolf Capital - Limited Partnership reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 28, 2021 | PSTI | ↓ Sell | 210,892 | $3.71 | $782K | Direct | Jun 1, 2021 (4d) |
| May 26, 2021 | PSTI | ↓ Sell | 144,678 | $3.68 | $533K | Direct | Jun 1, 2021 (6d) |
| May 25, 2021 | PSTI | ↓ Sell | 261,238 | $3.84 | $1.0M | Direct | May 27, 2021 (2d) |
| May 24, 2021 | PSTI | ↓ Sell | 149,138 | $3.90 | $582K | Direct | May 27, 2021 (3d) |
| May 3, 2021 | PSTI | ↓ Sell | 189,725 | $4.61 | $875K | Direct | May 4, 2021 (1d) |
| Nov 30, 2020 | PSTI | ↑ Buy | 20,000 | $9.70 | $194K | Direct | Dec 1, 2020 (1d) |
| Oct 30, 2020 | PSTI | ↑ Buy | 50,000 | $9.51 | $476K | Direct | Nov 3, 2020 (4d) |
| Oct 29, 2020 | PSTI | ↑ Buy | 20,000 | $9.20 | $184K | Direct | Oct 29, 2020 (0d) |
| Sep 30, 2020 | PSTI | ↑ Buy | 199,129 | $10.16 | $2.0M | Direct | Oct 1, 2020 (1d) |
| Sep 28, 2020 | PSTI | ↑ Buy | 13,189 | $9.49 | $125K | Direct | Sep 29, 2020 (1d) |
| Sep 24, 2020 | PSTI | ↑ Buy | 34,800 | $9.02 | $314K | Direct | Sep 25, 2020 (1d) |
| Sep 23, 2020 | PSTI | ↑ Buy | 10,734 | $9.04 | $97K | Direct | Sep 24, 2020 (1d) |
| Jul 31, 2020 | PSTI | ↑ Buy | 65,771 | $9.24 | $608K | Direct | Aug 3, 2020 (3d) |
| Jul 29, 2020 | PSTI | ↑ Buy | 121,926 | $9.03 | $1.1M | Direct | Jul 30, 2020 (1d) |
| Jul 28, 2020 | PSTI | ↑ Buy | 81,198 | $8.46 | $687K | Direct | Jul 29, 2020 (1d) |
| Jul 27, 2020 | PSTI | ↑ Buy | 49,396 | $8.34 | $412K | Direct | Jul 28, 2020 (1d) |
| Jun 29, 2020 | PSTI | ↑ Buy | 199,686 | $8.04 | $1.6M | Direct | Jul 7, 2020 (8d) |
| Jun 18, 2020 | PSTI | ↑ Buy | 700,449 | $7.61 | $5.3M | Direct | Jun 29, 2020 (11d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Clover Wolf Capital - Limited Partnership's insider trades
Clover Wolf Capital - Limited Partnership is a 10% owner of Pluristem Therapeutics (PSTI). Since Jun 18, 2020, it has reported 13 open-market purchases worth $13.2M and 5 sales worth $3.8M on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PSTI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.